Piramal Life may develop TB drug with leads from Antarctica
P B Jayakumar / Mumbai September 17, 2008, 1:02 IST Piramal Life Sciences, the demerged research arm of pharmaceutical major Nicholas Piramal India (NPIL), may become the first company to successfully develop a tuberculosis drug whose leads are isolated from the living organisms found in ice brought from the Antarctica region. "The scientists with Piramal Life Sciences (PLSL) has identified additional leads that will help to develop drugs to treat tuberculosis and other infections," revealed Swati Piramal, director, Nicholas Piramal.